The Analyst Verdict: Xylem In The Eyes Of 7 Experts
Portfolio Pulse from Benzinga Insights
Xylem (NYSE:XYL) has been analyzed by 7 analysts, showing a shift towards a more bullish outlook with an average 12-month price target of $142.86, up from $133.00. The company's financials reveal strong revenue growth and net margin, but challenges in ROE and ROA. Xylem's market position is solid, with a significant market capitalization and a lower than average debt-to-equity ratio.
April 18, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xylem's stock may see positive short-term movement due to upgraded analyst ratings and a higher average price target of $142.86, indicating strong confidence in the company's financial health and market position.
The increase in the average price target to $142.86 from $133.00, along with positive revenue growth and a strong market position, suggests analysts see Xylem as undervalued. The bullish sentiment among analysts, combined with the company's solid financial performance, is likely to attract investor interest and drive up the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100